Tag Archives: Martin McGlynn

Stem Cells Inc. update at Alliance for Regenerative Medicine (ARM)

Martin McGlynn, President and CEO of Stem Cells Inc. gives an update on Investor Day in New York City. For spinal cord injury they plan to release data in the second quarter of 2014 and open 20-30 additional sites to … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research | Tagged , ,

CNS Panel Discussion, StemCells Inc. and Asterias Biotherapeutics at Alliance for Regenerative Medicine Investor Day

The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research | Tagged , , , , , , , , , , , , , , , , , , ,